The AI-Mind Final General Assembly successfully concludes in Rome
The AI-Mind consortium successfully concluded its 11th General Assembly (GA), held from 14 to 16 December 2025 in Rome, Italy, bringing together more than 50 partners in person, with additional participants joining remotely. The meeting marked a key moment of alignment and strategic consolidation as the project enters its final phase, concluding at the end of February 2026.
The General Assembly officially opened on 15 December with a warm welcome from the project coordinator, Ira Hebold Haraldsen (Oslo University Hospital ), together with the hosting teams from The Scientific Institute for Research, Hospitalization and HealthCare (IRCCS), Università Cattolica del Sacro Cuore (UCSC) and Neuroconnect Srl (Neuroconnect). The opening session set the stage for intensive technical, scientific and strategic discussions across the consortium.
A highlight of the meeting was the keynote lecture delivered by Prof. Camillo Marra (USCS) entitled “Disease or Dementia: the ruined landscape of Alzheimer’s diagnosis after biomarkers’ invasion”, which provided valuable clinical insights and sparked multidisciplinary discussion among participants.
Throughout the three days, partners covered all core topics outlined in the agenda, with a strong focus on the AI-Mind Connector and Predictor. Discussions centred on:
- advances in machine learning and deep learning algorithms and related code development,
- data curation, harmonisation and modelling, leveraging data collected across multiple countries,
- progress on the AI-Mind tools and their clinical and technological validation,
- health technology assessment, project management, and dissemination and exploitation activities.
The General Assembly enabled fruitful exchanges between interdisciplinary teams, strengthening collaboration between clinicians, data scientists, AI experts, and innovation and communication specialists. Partners agreed on strategies to ensure the sustainability, uptake and long-term value of the project results beyond its formal end.
Dedicated sessions also addressed joint publication strategies and coordinated approaches to disseminating results, as well as ways to harmonise follow-up communication with study participants after the project concludes. These discussions are essential to ensuring ethical engagement, transparency and continued trust with participants.
Looking ahead to the final months of the project, partners reaffirmed their commitment to producing the remaining deliverables, guidelines and recommendations, including:
- policy briefs,
- innovative clinical guidelines,
- reports on innovation pathways and the use of the AI-Mind tools,
- and a comprehensive assessment of acceptance, understanding and trustworthiness of the AI-Mind solutions from key stakeholder groups.
All public reports and resources generated within AI-Mind will be available then via AI-Mind Share.
Members of the Scientific Advisory Board (SAB) expressed strong appreciation for the consortium’s achievements to date and provided strategic recommendations for the final phase, notably highlighting the importance of securing future funding to further exploit and build upon the rich datasets and results generated by AI-Mind.
Beyond the formal sessions, discussions continued during the networking dinner, further reinforcing collaboration across the consortium. The 11th General Assembly thus represented not only a moment of progress review, but also a decisive step towards maximising the scientific, clinical and societal impact of the AI-Mind project.